Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ayr Wellness Inc C.AYR.A

Alternate Symbol(s):  AYRWF

AYR Wellness Inc. is a vertically integrated multi-state cannabis operator in the United States. The Company operates simultaneously as a retailer with more than 90 licensed dispensaries and a house of cannabis consumer packed goods (CPG) brands. It is a cultivator, manufacturer and retailer of cannabis products and branded CPG, and is engaged in the manufacture, possession, use, sale, or... see more

CSE:AYR.A - Post Discussion

Ayr Wellness Inc > AYR OPENS new dispensary in Montgomeryville , Pennsylvania
View:
Post by Humanist on Nov 12, 2021 8:45am

AYR OPENS new dispensary in Montgomeryville , Pennsylvania

Ayr Wellness Adds to Pennsylvania Footprint, Opens New Dispensary in Montgomeryville

 by @nasdaq on 12 Nov 2021, 08:00
   
MIAMI, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator (“MSO”), today announced the opening of Ayr Wellness Montgomeryville, the Company’s seventh affiliated dispensary operating in the Commonwealth of Pennsylvania.
Jonathan Sandelman, Founder, Chairman and CEO of Ayr, said, “We continue to appreciate the warm reception that we’ve received from Pennsylvania’s patient community, a particularly discerning group with a keen understanding of quality. We consistently strive to deliver the best quality product at an accessible price. And now, with a seven-store footprint and robust wholesale operation, we look forward to introducing more Pennsylvania patients to the Ayr way.”

The Montgomeryville dispensary is located at the "Five Points" junction, a popular shopping area in Montgomeryville, PA. The 8,400 sq. ft. store continues the rapid expansion of the Ayr organization’s presence in Pennsylvania’s burgeoning medical marijuana market.

Montgomeryville is a northern suburb of Philadelphia, located in Montgomery County, the third most populous county in Pennsylvania, with over 850,000 residents according to the 2020 Census.

The new location features a curated selection of high-quality medical marijuana products, including Ayr-owned brands Origyn Extracts, Seven Hills flower, and Revel flower, as well as products sourced from third-party brands throughout the state. The store has 12 point of sale (“POS”) stations and 46 parking spaces.

Pennsylvania has a robust and growing medical marijuana market with over 633,000 patients, 132 licensed dispensaries and 29 operational licensed cultivators/processors. Annual industry-wide statewide marijuana sales in Pennsylvania are expected to surpass $1 billion by 2024, according to BDSA.

The Ayr organization has nine dispensary licenses in the Commonwealth (seven currently open), complementing the Company’s close to 200,000 sq. ft. of cultivation and production space, pending completion of expansion plans.
 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities